Senior Scientist

Zymergen is a biotechnology company that specializes in machine learning, big data, and artificial intelligence.

Zymergen is a biotechnology company that specializes in the fields of machine learning, big data, and artificial intelligence. The company partner with nature to create materials and products across industries from agriculture to electronics, consumer care to pharmaceuticals, and more.

Zymergen

Senior Scientist, RNA Therapeutics

Structure Therapeutics specializes in the discovery and development of drugs against a type of targets called GPCR.

Structure Therapeutics creates life-changing medicines for patients using advanced computational and structure-based technology. Our platform combines the latest advancements in computational chemistry, visualization of molecular interactions, and data integration to design orally available, superior medicines that overcome current limitations in biologic and peptide drugs. We are advancing our clinical-stage pipeline of differentiated, efficacious and safe treatments focused on chronic diseases with high unmet need, including cardiovascular, metabolic and pulmonary conditions. At Structure, our team‚Äôs deep experience with complex biological targets and mechanisms, structure-based drug design, and global drug discovery and development enables our bold vision: to design and develop world-class medicines with tremendous patient impact and broad commercial opportunity.

Structure Therapeutics

Senior Scientist, Pharmacology

Strand Therapeutics is a biopharmaceutical company applying synthetic biology to RNA therapeutics to develop single dose mRNA treatments.

Strand Therapeutics is a developer of a biotechnology platform intended to create gene therapies powered by synthetic biology.The company's offerings include immunotherapies to help cells produce target cancer-killing proteins during immunotherapy, enabling patients to improve their body's immune system to fight cancer.

Strand Therapeutics

Senior Associate Scientist, mRNA Automation

SpringWorks Therapeutics is a biopharmaceutical company focused on developing medicines for patients with severe rare diseases and cancer.

SpringWorks is a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for patients living with severe rare diseases and cancer. SpringWorks has a differentiated targeted oncology pipeline spanning solid tumors and hematological cancers, including two potentially registrational clinical trials in rare tumor types as well as several programs addressing highly prevalent, genetically defined cancers. SpringWorks‚Äô strategic approach and operational excellence in clinical development have enabled it to rapidly advance its two lead product candidates into late-stage clinical trials while simultaneously entering into multiple shared-value partnerships with innovators in industry and academia to unlock the full potential for its portfolio and create more solutions for patients with cancer.

SpringWorks Therapeutics

Discovery Chemistry Senior Scientist II

Translational Medicine Senior Scientist

SES is a manufacturer and developer of Hybrid Li-Metal Batteries for electric vehicles.

SolidEnergy manufactures rechargeable cells at a pilot scale for prototype demonstration and specialized aerospace markets. But their real future lies in the materials they supply‚Äîanodes and electrolyte‚Äîfor mainstream markets such as consumer electronics and electric vehicles. They supply these to large Li-ion cell manufacturers to be integrated with a separator and cathode into full cells which can be customized for different applications including drones, consumer electronics, and electric vehicles. Because their anode and electrolyte materials are compatible with existing Li-ion cell manufacturing processes, they can achieve scalability by using existing infrastructure. This eliminates the need for costly infrastructure investment. It‚Äôs all part of their open ecosystem. It means a more seamless end-user experience, faster prototyping, and no limits to growth.

Advanced Platform Development - Failure Analysis (Senior Scientist / Scientist)

Senior Scientist, Material Characterization

Orbital Therapeutics is a biotechnology company that develops RNA-based medicines to treat disease in humans.

Orbital Therapeutics aims to enhance global health by unleashing the full potential of RNA-based medicines to treat human disease in ways that were not previously possible. To produce an extended portfolio of medications, the company is developing an innovative platform at the confluence of RNA technology, delivery techniques, data analytics, and automation.

Location

Company Stage

Age of Data

Experience

Industry

Company

Senior Scientist

Zymergen

N/A

N/A

Structure Therapeutics

N/A

N/A

Strand Therapeutics

N/A

N/A

SpringWorks Therapeutics

N/A

N/A

SES

N/A

N/A

Orbital Therapeutics

N/A

N/A